SCHEMBL6880141

SCHEMBL6880141

COc1ccc(NC(=O)NC2CCC(Nc3cc(N(C)C)c4ccccc4n3)CC2)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.52
MAPT P10636 6/20 0.49
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
ADRA2A P08913 1/20 0.47
MCHR1 Q99705 1/20 0.47
TP53 P04637 3/20 0.46
DRD2 P14416 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
KDR P35968 1/20 0.45
ATM Q13315 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6880135 1.00 SIGMAR1 (0.52) SIGMAR1MAPTLMNAKDM4EALDH1A1
SCHEMBL6880935 0.92 ADRA2A (0.47) SIGMAR1MAPTLMNAKDM4EADRA2A
SCHEMBL6880943 0.92 ADRA2A (0.47) SIGMAR1MAPTLMNAKDM4EADRA2A
SCHEMBL6457835 0.90 ALDH1A1 (0.47) MAPTLMNAKDM4EALDH1A1ADRA2A
SCHEMBL6457820 0.90 ALDH1A1 (0.47) MAPTLMNAKDM4EALDH1A1ADRA2A
SCHEMBL6461805 0.87 IGF1R (0.54) MAPTLMNAKDM4EALDH1A1POLB
SCHEMBL6461800 0.87 IGF1R (0.54) MAPTLMNAKDM4EALDH1A1POLB
SCHEMBL6467397 0.85 MAPT (0.45) MAPTLMNAPOLBADRA2AMCHR1
SCHEMBL6880545 0.85 MAPT (0.54) MAPTPOLBADRA2AMCHR1KDR
SCHEMBL6880550 0.85 MAPT (0.54) MAPTPOLBADRA2AMCHR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed